C-1311 Drug Record

  • C-1311 chembl:CHEMBL338604 Antineoplastic

    Alternate Names:

    NSC-645809

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • C-1311   NQO2

    Interaction Score: 0.82

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • C-1311   TOP2A

    Interaction Score: 0.31

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction DNA topoisomerase II inhibitor
    Trial Name C-1311, XLS-002,Symadex

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • C-1311   TOP2B

    Interaction Score: 0.29

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction DNA topoisomerase II inhibitor
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • C-1311   FLT3

    Interaction Score: 0.15

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Tyrosine-protein kinase receptor FLT3 inhibitor

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • C-1311   TOP1

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name C-1311, XLS-002,Symadex
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial